TP53 and osteosarcoma: Nuclear extracts of SaOS-2 (p53-/-) osteosarcoma cells that stably express the carboxy-terminal fragment of p73α (p73DD) [37], [38] treated with camptothecin were immunoprecipitated either with anti-p73 antibodies or control antibodies.